Evolution

Overview

Legacy LACE was an outdated auditory training product with limited scalability, no AI capabilities, and a user experience that couldn't support the clinical outcomes patients needed. I led the complete strategic redesign and platform modernization into Lace AI Pro, an AI-powered, cross-platform digital therapeutic deployed in over 1,000 clinics nationwide.

This was a 0→1 evolution in a regulated healthcare environment: an FDA Class II device, designed end-to-end in under six months.

The platform's clinical outcomes, validated across 6,137 patients in Q1 2025 analysis by Dr. Miles Aron, outperform all previous clinical studies in auditory training. Speech-in-noise improvement of +2.6 dB SNR at therapeutic dose. Rapid speech comprehension gains of +36 WPM in under a month. Working memory response times improving by over 1.5 seconds at effective dose, up to 8 seconds in severe cases.

The design decisions that made the platform work weren't cosmetic. They were clinical.

The Problem

The auditory training market was accelerating. Consumer apps and AI-first competitors were raising the bar on personalization and accessibility, while Legacy LACE remained a browser-based, single-platform product with no AI roadmap and a fixed content library that couldn't scale to new patient populations. Staying still was falling behind.

• Legacy product was outdated with no path to AI integration
• Fixed content library constrained applicability to new patient populations (APD, Hidden Hearing Loss)
• Single-platform delivery didn't match how patients actually live and train
• Competitive products were rapidly advancing on personalization and UX

“

Lace made me feel less like one more defective senior waiting on a medical miracle. I could participate in my own treatment. I could actually help myself. It's easy, it's affordable, it's fun.

The Strategy

1. Positioned Dynamic Threshold Training Engine™ technology. A core adaptive layer that adjusts training difficulty in real time based on patient performance. The DTTE optimizes neuroplasticity by keeping patients at the threshold of their ability (~50% accuracy), the precise zone where the brain learns most efficiently. Validated: speech-in-noise improvements follow a strong log fit with R²=0.92 across 6,137 patients, outperforming all prior auditory training clinical studies.

2. Expanded content architecture adding 10,000+ exercises across 27 topics, enabling broader patient applicability (APD, Hidden Hearing Loss, mild HL).

3. Designed an AI coaching and personalization layer including the Familiar Voices feature and AI Avatar guide system.

4. Built cross-platform accessibility across iOS, Android, and Desktop to meet patients where they are.

Key Design Decisions

• App-based cross-platform accessibility
• Lifetime license and subscription model framing, aligning the business model with patient commitment, reinforcing long-term engagement over episodic use
• Multi-modal training types: Speech-in-Noise, Working Memory, Rapid Speech, Missing Word
• A training-type selector creating clear clinical context and dosing guidance
• Content library architecture surfacing 10,000+ exercises without cognitive overwhelm
• Ease-in / ease-out "softball" mechanics designed to build patient confidence while maintaining engagement at threshold, a behavioral design choice with direct clinical validation

Key Screens

Clinical Outcomes

This data strongly outperforms all previous clinical studies in auditory training.

Speech-in-noise training

• +2.6 dB SNR improvement at effective dose (250+ exercises, <1 month)
• +6–9 dB SNR at higher training doses, life-changing for severe patients
• +6–8 dB in severe-to-profound hearing loss cases
• Corresponds to a 15–40% increase in word recognition

Rapid speech training

• +36 WPM average improvement at 250+ exercises (<1 month)
• Range: +35–60 WPM, the difference between being lost and keeping up in conversation
• Benefits patients across the full severity spectrum, including those without hearing loss

Working memory training

• >1.5 seconds faster response time at effective dose (100+ exercises)
• Up to 8 seconds gained in daily conversation for severe cases
• Improvements scale predictably with training dose (R²=0.76)

Missing word training

• Severe cases: 6.8 seconds improvement in response time while advancing to higher difficulty levels
• Average patient advanced from Level 1 to Level 3–5 difficulty

Outcomes & Impact

• Enabled broader patient applicability: APD, HHL, mild HL, and severe-to-profound populations
• Clinical data outperforms all previous auditory training studies (Dr. Miles Aron, Q1 2025)
• 37–48% patient compliance vs. 30% for physical therapy. Lace AI Pro beats the established standard across all four training types
• Strengthened product differentiation in a competitive market
• Supported FDA Class II medical device positioning
• Deployed across 1,000+ clinics in under one year
• Hearing Technology Innovator Award recipient (2024, 2025)

Collaboration

This was a full cross-functional build. I aligned engineering (adaptive algorithm constraints and cross-platform architecture), clinical research (therapeutic validity of training types and dosing thresholds), product marketing (platform narrative and FDA Class II positioning), and executive leadership (go-to-market timing and licensing model).

Leadership

• Platform vision and architecture design
• 0→1 product leadership at speed
• Innovation within regulatory constraints
• Cross-functional alignment across engineering, clinical, marketing, and executive teams